Literature DB >> 18278519

The neurogenic bladder: introducing four contributions.

Willem Proesmans1.   

Abstract

Neurogenic bladder dysfunction in children is frequently seen in patients with meningomyelocele (MMC). The disorder carries a high risk for all kinds of complications, with renal damage being the most important. More than 95% of MMC patients have a neurogenic bladder, the paramount manifestation of which is a disturbed coordination between detrusor and sphincter muscles. This vesicourethral dysfunction leads to defective filling and emptying of the urinary bladder. Voiding at will is almost never possible. According to the location and extent of the neural tube lesion, patients have either an atonic or a hypertonic pelvic floor and either an atonic or a hypertonic detrusor, leading to four classic combinations. Hypertonic sphincter and detrusor hyperactivity lead to the most dangerous form of neurogenic bladder, referred to as the "unsafe" bladder. The presence of residual urine in a high-pressure container causes either decompensation of the detrusor with vesicoureteral reflux or deterioration of the bladder wall with hypertrophy and stiffness resulting in uterovesical obstruction. The subsequent insufficient drainage of the upper urinary tract leads to decompensation of the ureters and finally to chronic renal disease, the process being accelerated by urinary tract infections. The aim of treatment is to restore as much as possible both essential functions: urine storage and timely emptying of the reservoir. What should and can be achieved is a more or less adequate, low-pressure, functional capacity of the bladder that is emptied as completely as possible by clean intermittent catheterization (CIC). MMC leads to the prototype of neurogenic bladder in childhood. What we know and what we do for MMC patients can roughly be applied to all other forms of neurogenic bladder, either congenital or acquired.

Entities:  

Mesh:

Year:  2008        PMID: 18278519     DOI: 10.1007/s00467-008-0768-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Treatment of the occult tethered spinal cord for neuropathic bladder: results of sectioning the filum terminale.

Authors:  P D Metcalfe; T G Luerssen; S J King; M Kaefer; K K Meldrum; M P Cain; R C Rink; A J Casale
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

Review 2.  Bladder-sphincter dysfunction in myelomeningocele.

Authors:  J D van Gool; P Dik; T P de Jong
Journal:  Eur J Pediatr       Date:  2001-07       Impact factor: 3.183

3.  Nocturnal bladder emptying: a simple technique for reversing urinary tract deterioration in children with neurogenic bladder.

Authors:  Stephen A Koff; Michael R Gigax; Venkata R Jayanthi
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

Review 4.  Botulinum toxin injections for paediatric incontinence.

Authors:  Brigitte Schurch; Jacques Corcos
Journal:  Curr Opin Urol       Date:  2005-07       Impact factor: 2.309

5.  The influence of colonic enema irrigation on urodynamic findings in patients with neurogenic bladder dysfunction.

Authors:  L M de Kort; C H Nesselaar; J D van Gool; T P de Jong
Journal:  Br J Urol       Date:  1997-11

6.  Lower urinary tract dysfunction in children with benign sacrococcygeal teratoma.

Authors:  T M Boemers; J D van Gool; T P de Jong; K M Bax
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

Review 7.  Neurogenic bladder: etiology and assessment.

Authors:  Stuart B Bauer
Journal:  Pediatr Nephrol       Date:  2008-02-13       Impact factor: 3.714

Review 8.  The neurogenic bladder: medical treatment.

Authors:  Carla Verpoorten; Gunnar M Buyse
Journal:  Pediatr Nephrol       Date:  2007-12-19       Impact factor: 3.714

Review 9.  Treatment of the neurogenic bladder in spina bifida.

Authors:  Tom P V M de Jong; Rafal Chrzan; Aart J Klijn; Pieter Dik
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 10.  Myelomeningocele: neglected aspects.

Authors:  Christopher R J Woodhouse
Journal:  Pediatr Nephrol       Date:  2008-01-17       Impact factor: 3.714

  10 in total
  3 in total

1.  Intradetrusor injection of botulinum toxin A in children: a 10-year single centre experience.

Authors:  Riyad Peeraully; Christine Lam; Nikita Mediratta; Ramnik Patel; Alun Williams; Manoj Shenoy; Nia Fraser
Journal:  Int Urol Nephrol       Date:  2019-06-10       Impact factor: 2.370

2.  Do current bladder smooth muscle cell isolation procedures result in a homogeneous cell population? Implications for bladder tissue engineering.

Authors:  Arun K Sharma; Jena L Donovan; Jennifer A Hagerty; Ryan R Sullivan; Seby L Edassery; Daniel A Harrington; Earl Y Cheng
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

3.  Voiding dysfunction in children causes, management, and prognosis: A single-center retrospective study.

Authors:  Sherif M El Desoky; Mai Banakhar; Khalid Khashoggi; Zaher F Zaher; Jameela A Kari
Journal:  Saudi Med J       Date:  2021-08       Impact factor: 1.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.